Oscar Health (NYSE:OSCR) Announces Quarterly Earnings Results, Misses Estimates By $0.07 EPS

Oscar Health (NYSE:OSCR) released its quarterly earnings data on Tuesday. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07), Zacks reports. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%.

Oscar Health Price Performance

OSCR traded down $1.49 on Tuesday, reaching $15.27. The company had a trading volume of 9,975,786 shares, compared to its average volume of 3,348,879. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health has a 52-week low of $12.84 and a 52-week high of $23.79. The company has a market cap of $3.77 billion, a price-to-earnings ratio of -254.37, a P/E/G ratio of 0.67 and a beta of 1.73. The business has a 50 day simple moving average of $15.22 and a 200 day simple moving average of $16.85.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on OSCR shares. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price for the company. Finally, Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and an average target price of $21.56.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now owns 81,962 shares of the company’s stock, valued at $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Steven Wolin sold 19,580 shares of Oscar Health stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the transaction, the chief operating officer now directly owns 102,598 shares in the company, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders purchased 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.